Cyanamide hepatotoxicity. Incidence and clinico-pathological features.
Ground-glass hepatocytes resembling those seen in HBsAg carriers on hematoxylin and eosin and on trichrome stained sections, but giving a negative reaction to orcein and a positive one to PAS, were found in liver biopsy specimens from nine asymptomatic former alcoholics who were on treatment with cyanamide, in one of four who had been treated with cyanamide several months before the liver biopsy procedure, in none of 15 treated with disulfiram, and in one of eight who had apparently not received aversive drugs. Portal and periportal inflammatory changes and fibrosis were more frequently observed in biopsy specimens containing PAS-positive ground-glass hepatocytes than in those without, but cirrhosis was found with a similar frequency. It is concluded that periportal PAS-positive ground-glass hepatocytes are a histological marker of cyanamide treatment.
Bruguera
M
M
Liver Unit, Hospital Clinic i Provincial, University of Barcelona, Spain.
Parés
A
A
Heredia
D
D
Rodés
J
J
D000328:Adult; D000437:Alcoholism / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D003484:Cyanamide / Q000009:adverse effects* / Q000627:therapeutic use; D003486:Cyanides / Q000009:adverse effects*; D004221:Disulfiram / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010503:Periodic Acid-Schiff Reaction; D011446:Prospective Studies
D003486:Cyanides; D003484:Cyanamide; D004221:Disulfiram